> Contact us

IMPLEMENTING REAL-TIME MONITORING AND MAKING IT A SUCCESS STORY

There are several success stories on how real-time monitoring has saved high value products and ensured drug availability. However, Niclas Ohlsson, CEO at TSS, believes companies need to carefully assess and plan before deciding to implement real-time monitoring in their life science supply chains.

Scroll to read on 

I

In the TSS real-time application you can follow your most valuable shipments live, all the way to the last mile. Although this type of application opens up for huge possibilities, it is important to remember that it also requires companies to think through how the organisation and its processes are affected.


This typically calls for an escalation process as well as an organization that is available 24/7, with a global operation team that can, if needed, interact and initiate corrective actions. In the complex eco system of a supply chain, that may involve different companies, experts need to be accessible and actionable.

The first impact of implementing real-time monitoring is the need for a control tower. This control tower must be able to capture all alarms, to be qualified to interpret them, and to conclude what action is suitable, and by whom

Before deciding to implement real-time monitoring, you need to ask yourself: is there a risk that we turn our organization into a reactive rather than a proactive organization? And what is the cost for that?

Niclas Ohlsson says, that, in order to assess the possible effectiveness of real-time monitoring, the supply chain’s white and dark spaces need to be identified. Depending on how your supply chain has been set up, it is important to map areas where possible actions can be taken, but also where it can not be. This information should be mapped against historical data where issues are typically initiated or escalating.


“If there is a high positive overlap, the analysis should assess the causes for the deviation. Knowing this, you need to assess how such a situation can be addressed in the field - which action is required?”


The percentage of cases that could be addressed, and the cost for these real time actions, should then be compared with a proactive action that could alternatively resolve the issue.

To make sure your real-time monitoring experience becomes a success stories, it is crucial that you know which questions to ask during the evaluation process, and what to expect from the vendor. 

> Download TSS’ buyer’s guide to real-time temperature monitoring to learn more!

Go to article: Home | Maximising ManufacturingGo to article: EditorialGo to article: Pfanstiehl Company InsightGo to article: PfanstiehlGo to article: ContentsGo to article: Daiichi JitsugyoGo to article: MedelpharmGo to article: NewsGo to article: B & W Tek Go to article: The Pharma Industry BriefingGo to article: Clinical trial transparency in the Americas Go to article: Malvern Panalytical Company InsightGo to article: Malvern PanalyticalGo to article: AralabGo to article: Gene and cell therapies: making manufacturing workGo to article: Capsugel Company InsightGo to article: Abiogen PharmaGo to article: Amazon and PillPack: an unstoppable pharmacy force?Go to article: GerresheimerGo to article: SGSGo to article: Cancer trials: making the most of biomarkersGo to article: SmartCAE Company InsightGo to article: SmartCAEGo to article: The highs and lows of hormone replacement therapyGo to article: EcocoolGo to article: LaudaGo to article: Verge Genomics: employing AI to improve drug discoveryGo to article: AirBridgeCargo Company InsightGo to article: AirBridgeCargoGo to article: Senn ChemicalsGo to article: What can life sciences firms really achieve with AI?Go to article: Pall BiotechGo to article: CBDepotGo to article: G.F.Go to article: Setting practical parameters for more accurate regulatory resourcingGo to article: TSS ABGo to article: MasterpackGo to article: HOF SonderanlagenbauGo to article: Röchling Medical NeuhausGo to article: Cannabis branding: Marketing an industry from the ground upGo to article: AlpexGo to article: PharmasolGo to article: EventsGo to article: AECO Telecom & Security SystemsGo to article: Event: CPhI WorldwideGo to article: HTI PlasticsGo to article: SanofiGo to article: Event: Outsourcing in Clinical Trials DACH 2018Go to article: Procaps Company InsightGo to article: ProcapsGo to article: Event: Big Data & Analytics for Pharma Summit Go to article: Wilhelm Haselmeier GmbH & Co KG Company InsightGo to article: Wilhelm Haselmeier GmbH & Co. KGGo to article: Next issueGo to article: Scandinavian Health Ltd. Company InsightGo to article: Scandinavian Health Ltd.Go to article: ILC Dover IncGo to article: Scilabware